Market Research Logo

Global In-Vitro Diagnostics (IVD) Market Report: Insights, Trends and Forecast (2019-2023)

Global In-Vitro Diagnostics (IVD) Market Report: Insights, Trends and Forecast (2019-2023)

The global IVD market value is forecasted to reach US$92.54 billion in 2023, growing at a CAGR of 6.6%, for the period spanning from 2018 to 2023. The factors such as increasing diabetic patient count, surging chronic ailments incidence, rising healthcare expenditure, growing geriatric population, accelerating economic growth and improving consumer confidence are expected to drive the market growth. However, growth of the industry would be challenged by stringent regulations and intense competition. A few notable trends include development of syndromic panel, rising companion diagnostic tests preference by physicians, escalating research and development expenditures, applications of human microbiome in IVD, liquid biopsy for cancer testing and high IVD per capita expenditure in Europe.

The modern IVD industry comprises of three types of products namely; reagents, analytical instruments and accessory products that are required to perform an array of diagnostic laboratory tests and thereby helping the individual to monitor different types of diseases.

The fastest growing regional market is North America, owing to rise in incidence & prevalence of chronic diseases, technological advancements in testing techniques and the increase in healthcare expenditure by population. The U.S. represents one of the largest market for IVD and is already well-penetrated at developed market levels.

Scope of the report:

  • The report provides a comprehensive analysis of the global IVD market, segmented on the basis of product types i.e. reagents, instrumentations & software services and technologies i.e. immunodiagnostics, POCT, microbiology, SMBG, molecular diagnostics & clinical chemistry.
  • The major regional markets (North America, Asia-Pacific and Europe) have been analysed along with country coverage of the U.S., China, Japan, Australia, India, Germany, Italy and France.
  • The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players i.e. Roche Holding AG, Abbott Laboratories, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc. and Sysmex Corporation are also presented in detail.
Key Target Audience:
  • IVD Reagent/Instrument Manufacturers
  • Raw Material/Component Suppliers
  • End Users
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities


1. Market Overview
1.1 Introduction
1.2 IVD Product Types
Table 1: Types of IVD Products
1.3 IVD Tests
Table 2: Types of IVD Tests
1.4 Classification of IVD Technologies
Table 3: Classification of IVD Technologies
1.5 Application of IVD
1.6 IVD Value Chain Analysis
Table 4: IVD Value Chain Analysis
2. Global IVD Market Analysis
2.1 Global IVD Market Value Forecast
Table 5: Global IVD Market Value Forecast (2018-2023)
2.2 Global IVD Market Value by Product
Table 6: Global IVD Market Value by Product (2018)
2.2.1 Global Reagents Market Value Forecast
Table 7: Global Reagents Market Value Forecast (2018-2023)
2.2.2 Global Instrumentation Market Value Forecast
Table 8: Global Instrumentation Market Value Forecast (2018-2023)
2.2.3 Global Instrumentation Market Value by Segment
Table 9: Global Instrumentation Market Value by Segment (2018)
2.3 Global IVD Market Value by Technology
Table 10: Global IVD Market Value by Technology (2018)
2.3.1 Global Immunodiagnostic Market Value Forecast
Table 11: Global Immunodiagnostic Market Value Forecast (2018-2023)
2.3.2 Global Immunodiagnostic Market Value by Indication
Table 12: Global Immunodiagnostic Market Value by Indication (2018)
2.3.3 Global Self Monitoring Blood Glucose Market Value Forecast
Table 13: Global Self Monitoring Blood Glucose Market Value Forecast (2018-2023)
2.3.4 Global Point-of-Care Market Value Forecast
Table 14: Global Point-of-Care Market Value Forecast (2018-2023)
2.3.5 Global Point-of-Care Market Value by Product
Table 15: Global Point-of-Care Market Value by Product (2018)
2.3.6 Global Chemical Chemistry Market Value Forecast
Table 16: Global Chemical Chemistry Market Value Forecast (2018-2023)
2.3.7 Global Molecular Diagnostic Market Value Forecast
Table 17: Global Molecular Diagnostic Market Value Forecast (2018-2023)
2.3.8 Global Molecular Diagnostics Market Value by Indication
Table 18: Global Molecular Diagnostics Market Value by Indication (2018)
2.3.9 Global Hematology Market Value Forecast
Table 19: Global Hematology Market Value Forecast (2018-2023)
2.3.10 Global Microbiology Market Forecast
Table 20: Global Microbiology Market Forecast (2018-2023)
2.4 Global IVD Market Value by End User
Table 21: Global IVD Market Value by End User (2018)
2.5 Global IVD Market Value by Region
Table 22: Global IVD Market Value by Region (2018)
3. Regional IVD Market Analysis
3.1 North America
3.1.1 North America IVD Market Value Forecast
Table 23: North America IVD Market Value Forecast (2018-2023)
3.1.2 North America IVD Market Value by Country
Table 24: North America IVD Market Value by Country (2018)
3.1.3 The U.S. IVD Market Value Forecast
Table 25: The U.S. IVD Market Value Forecast (2018-2023)
3.2 Asia-Pacific
3.2.1 Asia-Pacific IVD Market Value Forecast
Table 26: Asia-Pacific IVD Market Value Forecast (2018-2023)
3.2.2 Asia-Pacific IVD Market Value by Country
Table 27: Asia-Pacific IVD Market Value by Country (2018)
3.2.3 China IVD Market Value Forecast
Table 28: China IVD Market Value Forecast (2018-2023)
3.2.4 Japan IVD Market Value Forecast
Table 29: Japan IVD Market Value Forecast (2018-2023)
3.2.5 Australia IVD Market Value Forecast
Table 30: Australia IVD Market Value Forecast (2018-2023)
3.2.6 India IVD Market Value Forecast
Table 31: India IVD Market Value Forecast (2018-2023)
3.3 Europe
3.3.1 Europe IVD Market Value Forecast
Table 32: Europe IVD Market Value Forecast (2018-2023)
3.3.2 Europe IVD Market Value by Country
Table 33: Europe IVD Market Value by Country (2018)
3.3.3 Germany IVD Market Value Forecast
Table 34: Germany IVD Market Value Forecast (2018-2023)
3.3.4 Italy IVD Market Value Forecast
Table 35: Italy IVD Market Value Forecast (2018-2023)
3.3.5 France IVD Market Value Forecast
Table 36: France IVD Market Value Forecast (2018-2023)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Diabetic Patient Count
Table 37: Global Diabetic Patient Count (2014/2035)
4.1.2 Surging Chronic Ailments Incidence
Table 38: Global New Cancer Patients Volume (2014-2018)
4.1.3 Rising HealthCare Expenditure
Table 39: Global Healthcare Expenditure Per Capita (2014-2018)
4.1.4 Growing Geriatric Population
Table 40: Global Ageing Population (2014-2018)
4.1.5 Accelerating Economic Growth
Table 41: Global GDP Per Capita (2014-2018)
4.1.6 Improving Consumer Confidence
Table 42: Consumer Confidence Index in US and Europe (2014-2018)
4.2 Key Trends and Developments
4.2.1 Development of Syndromic Panel
4.2.2 Rising Companion Diagnostic Tests Preference by Physicians
Table 43: Global Companion Diagnostic Test Market (2018-2023)
4.2.3 Escalating MedTech Research and Development Expenditures
Table 44: Global MedTech Research and Development Expenditures (2014-2018)
4.2.4 Applications of Human Microbiome in IVD
4.2.5 Liquid Biopsy for Cancer Testing
4.2.6 High IVD per Capita Expenditure in Europe
Table 45: Europe IVD per Capita Expenditure by Country (2018)
4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 Intense Competition
5. Competitive Landscape
5.1 Global IVD Market
5.1.1 Key Players – Market Share Comparison
Table 46: Key Players – Market Share Comparison (2018)
5.1.2 Key Players – Revenue Comparison
Table 47: Key Players – Revenue Comparison (2018)
5.1.3 Key Players – Market Cap Comparison
Table 48: Key Players – Market Cap Comparison (2019)
5.1.4 Key Players – Research & Development Expenditure Comparison
Table 49: Key Players – Research & Development Expenditure Comparison (2018)
5.1.5 Key Players – Molecular Diagnostics Market Share Comparison
Table 50: Key Players – Global Molecular Diagnostics Market Share Comparison (2018)
5.1.6 Key Players – Immunodiagnostics Market Share Comparison
Table 51: Key Players – Global Immunodiagnostics Market Share Comparison (2018)
5.1.7 Key Players – POCT Market Share Comparison
Table 52: Key Players – Global POCT Market Share Comparison (2018)
6. Company Profiles
6.1 Roche Holding AG
6.1.1 Business Overview
6.1.2 Financial Overview
Table 53: Roche Sales and Net Income (2014-2018)
Table 54: Roche Sales by Segments (2018)
Table 55: Roche Sales by Region (2018)
6.1.3 Business Strategies
6.2 Abbott Laboratories
6.2.1 Business Overview
Table 56: Abbott Laboratories Segment Overview
6.2.2 Financial Overview
Table 57: Abbott Laboratories Net Sales and Net Earnings (2014-2018)
Table 58: Abbott Laboratories Net Sales by Segments (2018)
Table 59: Abbott Laboratories Net Sales by Region (2018)
6.2.3 Business Strategies
6.3 Danaher Corporation
6.3.1 Business Overview
6.3.2 Financial Overview
Table 60: Danaher Sales and Net Earnings (2014-2018)
Table 61: Danaher Sales by Segment (2018)
6.3.3 Business Strategies
6.4 Siemens AG
6.4.1 Business Overview
6.4.2 Financial Overview
Table 62: Siemens Revenues and Net Income (2014-2018)
Table 63: Siemens Revenues by Segment (2018)
Table 64: Siemens Revenues by Region (2018)
6.4.3 Business Strategies
6.5 Thermo Fisher Scientific Inc.
6.5.1 Business Overview
6.5.2 Financial Overview
Table 65: Thermo Fisher Revenues and Net Income (2014-2018)
Table 66: Thermo Fisher Revenues by Segments (2018)
Table 67: Thermo Fisher Revenues by Region (2018)
6.5.3 Business Strategies
6.6 Sysmex Corporation
6.6.1 Business Overview
6.6.2 Financial Overview
Table 68: Sysmex Net Sales and Profit (2015-2019)
Table 69: Sysmex Net Sales by Segment (2019)
Table 70: Sysmex Net Sales by Region (2019)
6.6.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report